Breast Cancer Clinical Trial
Official title:
Use of Pre-Operative Hypnosis to Reduce Post-Operative Pain and Anesthesia Related Side-Effects
RATIONALE: Hypnosis may be effective in reducing pain and other side effects in women
undergoing surgery for breast cancer.
PURPOSE: This clinical trial is studying how well hypnosis works in reducing pain and other
side effects in women undergoing surgery for breast cancer.
OBJECTIVES:
- To test the feasibility of hypnosis as a pre-operative intervention for the reduction
of surgical- and anesthesia-related symptoms in women undergoing lumpectomy with
sentinel node biopsy, mastectomy, or mastectomy with lymph node dissection for locally
recurrent breast cancer.
- To identify the physical symptoms (i.e., pain, nausea, and vomiting) and psychological
symptoms (i.e., anxiety and distress) of patients undergoing hypnosis.
- To determine the length of stay in the Post Anesthesia Care Unit of patients undergoing
adjunct hypnosis.
- To describe patient satisfaction with the hypnosis experience.
- To determine the effect size and calculate the sample needed for a randomized clinical
trial using the results of this study.
OUTLINE: Patients undergo a scripted hypnotic intervention over 15 minutes within 1 hour
prior to their planned surgical procedure. Upon completion of the intervention, patients
proceed to the Preoperative Holding Area of the Surgery and Post Anesthesia Care Unit where
they receive the standard of care for lumpectomy with sentinel node biopsy, mastectomy, or
mastectomy with lymph node dissection.
Patients undergo collection of demographic information (i.e., age; gender; ethnicity;
marital/partnered status; spiritual practice; family members in the home; stress management
history; experience with the continuum of imagery/hypnosis practices; perceptions of
concentration abilities; and favorite aromas, colors, and scenes from nature) at the time of
consent using the Demographic Survey Questionnaire. They also undergo assessment of physical
and psychological symptoms (i.e., pain, nausea, vomiting, anxiety, and generalized distress)
at baseline (immediately prior to hypnotic induction) and after the intervention (prior to
discharge from the Post Anesthesia Care Unit).
;
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
| Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
| Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
| Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
| Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
| Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
| Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
| Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
| Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
| Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
| Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
| Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
| Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
| Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
| Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
| Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A |